Cardiac Differentiation of Mesenchymal Stem Cells: Impact of Biological and Chemical Inducers
- PMID: 33864233
- DOI: 10.1007/s12015-021-10165-3
Cardiac Differentiation of Mesenchymal Stem Cells: Impact of Biological and Chemical Inducers
Erratum in
-
Correction to: Cardiac Differentiation of Mesenchymal Stem Cells: Impact of Biological and Chemical Inducers.Stem Cell Rev Rep. 2021 Aug;17(4):1515. doi: 10.1007/s12015-021-10183-1. Stem Cell Rev Rep. 2021. PMID: 34033002 No abstract available.
Abstract
Cardiovascular disorders (CVDs) are the leading cause of global death, widely occurs due to irreparable loss of the functional cardiomyocytes. Stem cell-based therapeutic approaches, particularly the use of Mesenchymal Stem Cells (MSCs) is an emerging strategy to regenerate myocardium and thereby improving the cardiac function after myocardial infarction (MI). Most of the current approaches often employ the use of various biological and chemical factors as cues to trigger and modulate the differentiation of MSCs into the cardiac lineage. However, the recent advanced methods of using specific epigenetic modifiers and exosomes to manipulate the epigenome and molecular pathways of MSCs to modify the cardiac gene expression yield better profiled cardiomyocyte like cells in vitro. Hitherto, the role of cardiac specific inducers triggering cardiac differentiation at the cellular and molecular level is not well understood. Therefore, the current review highlights the impact and recent trends in employing biological and chemical inducers on cardiac differentiation of MSCs. Thereby, deciphering the interactions between the cellular microenvironment and the cardiac inducers will help us to understand cardiomyogenesis of MSCs. Additionally, the review also provides an insight on skeptical roles of the cell free biological factors and extracellular scaffold assisted mode for manipulation of native and transplanted stem cells towards translational cardiac research.
Keywords: Cardiac inducers; Cardiomyocytes; Exosomes; Growth factors; Mesenchymal stem cells; Microenvironment; micro RNA.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
References
-
- Jagannathan, R., Patel, S. A., Ali, M. K., & Narayan, K. M. V. (2019). Global updates on cardiovascular disease mortality trends and attribution of traditional risk factors. Current Diabetes Reports, 19(7), 44. https://doi.org/10.1007/s11892-019-1161-2 . - DOI - PubMed
-
- Roth, G. A., Johnson, C., Abajobir, A., Abd-Allah, F., Abera, S. F., Abyu, G., Ahmed, M., Aksut, B., Alam, T., Alam, K., Alla, F., Alvis-Guzman, N., Amrock, S., Ansari, H., Ärnlöv, J., Asayesh, H., Atey, T. M., Avila-Burgos, L., Awasthi, A., … Murray, C. (2017). Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. Journal of the American College of Cardiology, 70(1), 1–25. https://doi.org/10.1016/j.jacc.2017.04.052 .
-
- Hare, J. M., & Chaparro, S. V. (2008). Cardiac regeneration and stem cell therapy. Current Opinion in Organ Transplantation, 13(5), 536–542. - DOI
-
- Pendyala, L., Goodchild, T., Gadesam, R. R., Chen, J., Robinson, K., Chronos, N., & Hou, D. (2008). Cellular cardiomyoplasty and cardiac regeneration. Current Cardiology Reviews, 4(2), 72–80. https://doi.org/10.2174/157340308784245748 . - DOI - PubMed - PMC
-
- Eisenberg, L. M., Kubalak, S. W., & Eisenberg, C. A. (2004). Stem cells and the formation of the myocardium in the vertebrate embryo. The Anatomical Record. Part A, Discoveries in Molecular, Cellular, and Evolutionary Biology, 276(1), 2–12. https://doi.org/10.1002/ar.a.10130 . - DOI - PubMed - PMC
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
